#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=Micronutrients are essential to orchestrate all physiological functions .
2-1	16-30	Micronutrients	substance	new	coref	7-17[47_0]
2-2	31-34	are	_	_	_	_
2-3	35-44	essential	_	_	_	_
2-4	45-47	to	_	_	_	_
2-5	48-59	orchestrate	_	_	_	_
2-6	60-63	all	abstract[3]	new[3]	ana	3-2[0_3]
2-7	64-77	physiological	abstract[3]	new[3]	_	_
2-8	78-87	functions	abstract[3]	new[3]	_	_
2-9	88-89	.	_	_	_	_

#Text=Among them , iodine ( I ) plays a unique role because it is the main component of the thyroid hormones , i.e. , thyroxine ( T4 ) and triiodothyronine ( T3 ) .
3-1	90-95	Among	_	_	_	_
3-2	96-100	them	abstract	giv	_	_
3-3	101-102	,	_	_	_	_
3-4	103-109	iodine	substance	new	coref	8-16
3-5	110-111	(	_	_	_	_
3-6	112-113	I	person	acc	coref	4-13
3-7	114-115	)	_	_	_	_
3-8	116-121	plays	_	_	_	_
3-9	122-123	a	substance[7]	new[7]	ana	3-13[0_7]
3-10	124-130	unique	substance[7]	new[7]	_	_
3-11	131-135	role	substance[7]	new[7]	_	_
3-12	136-143	because	_	_	_	_
3-13	144-146	it	substance	giv	coref	3-15[9_0]
3-14	147-149	is	_	_	_	_
3-15	150-153	the	substance[9]	giv[9]	_	_
3-16	154-158	main	substance[9]	giv[9]	_	_
3-17	159-168	component	substance[9]	giv[9]	_	_
3-18	169-171	of	substance[9]	giv[9]	_	_
3-19	172-175	the	substance[9]|substance[11]	giv[9]|new[11]	appos	3-30[0_11]
3-20	176-183	thyroid	substance[9]|animal|substance[11]	giv[9]|new|new[11]	coref	4-3
3-21	184-192	hormones	substance[9]|substance[11]	giv[9]|new[11]	_	_
3-22	193-194	,	_	_	_	_
3-23	195-199	i.e.	animal[12]	new[12]	_	_
3-24	200-201	,	animal[12]	new[12]	_	_
3-25	202-211	thyroxine	animal[12]	new[12]	_	_
3-26	212-213	(	_	_	_	_
3-27	214-216	T4	abstract	new	_	_
3-28	217-218	)	_	_	_	_
3-29	219-222	and	_	_	_	_
3-30	223-239	triiodothyronine	substance	giv	_	_
3-31	240-241	(	_	_	_	_
3-32	242-244	T3	abstract	new	_	_
3-33	245-246	)	_	_	_	_
3-34	247-248	.	_	_	_	_

#Text=Since the thyroid gland regulates many metabolic processes , the extent of I requirement strongly depends on the age and stage of development of the individual .
4-1	249-254	Since	_	_	_	_
4-2	255-258	the	substance[17]	new[17]	coref	5-14[30_17]
4-3	259-266	thyroid	animal|substance[17]	giv|new[17]	coref	5-15
4-4	267-272	gland	substance[17]	new[17]	_	_
4-5	273-282	regulates	_	_	_	_
4-6	283-287	many	abstract[18]	new[18]	_	_
4-7	288-297	metabolic	abstract[18]	new[18]	_	_
4-8	298-307	processes	abstract[18]	new[18]	_	_
4-9	308-309	,	_	_	_	_
4-10	310-313	the	abstract[19]	new[19]	_	_
4-11	314-320	extent	abstract[19]	new[19]	_	_
4-12	321-323	of	abstract[19]	new[19]	_	_
4-13	324-325	I	abstract[19]|person|abstract[21]	new[19]|giv|new[21]	coref	5-5
4-14	326-337	requirement	abstract[19]|abstract[21]	new[19]|new[21]	_	_
4-15	338-346	strongly	_	_	_	_
4-16	347-354	depends	_	_	_	_
4-17	355-357	on	_	_	_	_
4-18	358-361	the	abstract[22]	new[22]	_	_
4-19	362-365	age	abstract[22]	new[22]	_	_
4-20	366-369	and	_	_	_	_
4-21	370-375	stage	abstract[23]	new[23]	_	_
4-22	376-378	of	abstract[23]	new[23]	_	_
4-23	379-390	development	abstract[23]|event[24]	new[23]|new[24]	coref	5-26[33_24]
4-24	391-393	of	abstract[23]|event[24]	new[23]|new[24]	_	_
4-25	394-397	the	abstract[23]|event[24]|person[25]	new[23]|new[24]|new[25]	_	_
4-26	398-408	individual	abstract[23]|event[24]|person[25]	new[23]|new[24]|new[25]	_	_
4-27	409-410	.	_	_	_	_

#Text=Thus , when the I demand is not satisfied , reduced functionality of the thyroid gland could occur ( hypothyroidism ) with negative consequences for proper mental development , body growth , and fertility .
5-1	411-415	Thus	_	_	_	_
5-2	416-417	,	_	_	_	_
5-3	418-422	when	_	_	_	_
5-4	423-426	the	abstract[27]	new[27]	_	_
5-5	427-428	I	person|abstract[27]	giv|new[27]	coref	6-10
5-6	429-435	demand	abstract[27]	new[27]	_	_
5-7	436-438	is	_	_	_	_
5-8	439-442	not	_	_	_	_
5-9	443-452	satisfied	_	_	_	_
5-10	453-454	,	_	_	_	_
5-11	455-462	reduced	abstract[28]	new[28]	_	_
5-12	463-476	functionality	abstract[28]	new[28]	_	_
5-13	477-479	of	abstract[28]	new[28]	_	_
5-14	480-483	the	abstract[28]|substance[30]	new[28]|giv[30]	_	_
5-15	484-491	thyroid	abstract[28]|animal|substance[30]	new[28]|giv|giv[30]	_	_
5-16	492-497	gland	abstract[28]|substance[30]	new[28]|giv[30]	_	_
5-17	498-503	could	_	_	_	_
5-18	504-509	occur	_	_	_	_
5-19	510-511	(	_	_	_	_
5-20	512-526	hypothyroidism	abstract	new	_	_
5-21	527-528	)	_	_	_	_
5-22	529-533	with	_	_	_	_
5-23	534-542	negative	abstract[32]	new[32]	_	_
5-24	543-555	consequences	abstract[32]	new[32]	_	_
5-25	556-559	for	abstract[32]	new[32]	_	_
5-26	560-566	proper	abstract[32]|event[33]	new[32]|giv[33]	_	_
5-27	567-573	mental	abstract[32]|event[33]	new[32]|giv[33]	_	_
5-28	574-585	development	abstract[32]|event[33]	new[32]|giv[33]	_	_
5-29	586-587	,	abstract[32]	new[32]	_	_
5-30	588-592	body	abstract[32]|object|event[35]	new[32]|new|new[35]	_	_
5-31	593-599	growth	abstract[32]|event[35]	new[32]|new[35]	_	_
5-32	600-601	,	abstract[32]	new[32]	_	_
5-33	602-605	and	abstract[32]	new[32]	_	_
5-34	606-615	fertility	abstract[32]|abstract	new[32]|new	_	_
5-35	616-617	.	_	_	_	_

#Text=For these reason , diet is often integrated with I supplements , generally provided through iodized salt .
6-1	618-621	For	_	_	_	_
6-2	622-627	these	abstract[37]	new[37]	coref	10-2[82_37]
6-3	628-634	reason	abstract[37]	new[37]	_	_
6-4	635-636	,	_	_	_	_
6-5	637-641	diet	event	new	coref	17-29[152_0]
6-6	642-644	is	_	_	_	_
6-7	645-650	often	_	_	_	_
6-8	651-661	integrated	_	_	_	_
6-9	662-666	with	_	_	_	_
6-10	667-668	I	person|substance[40]	giv|new[40]	coref	7-8
6-11	669-680	supplements	substance[40]	new[40]	_	_
6-12	681-682	,	substance[40]	new[40]	_	_
6-13	683-692	generally	substance[40]	new[40]	_	_
6-14	693-701	provided	substance[40]	new[40]	_	_
6-15	702-709	through	substance[40]	new[40]	_	_
6-16	710-717	iodized	substance[40]|substance[41]	new[40]|new[41]	_	_
6-17	718-722	salt	substance[40]|substance[41]	new[40]|new[41]	_	_
6-18	723-724	.	_	_	_	_

#Text=For infants , milk constitutes the only I source ; therefore , the dietary calibration of this micronutrients in dairy animals assumes relevant importance in order to obtain I-rich milk without inducing variations in animal performances .
7-1	725-728	For	_	_	_	_
7-2	729-736	infants	animal	new	_	_
7-3	737-738	,	_	_	_	_
7-4	739-743	milk	substance	new	coref	7-29[51_0]
7-5	744-755	constitutes	_	_	_	_
7-6	756-759	the	substance[45]	new[45]	_	_
7-7	760-764	only	substance[45]	new[45]	_	_
7-8	765-766	I	person|substance[45]	giv|new[45]	coref	8-5
7-9	767-773	source	substance[45]	new[45]	_	_
7-10	774-775	;	_	_	_	_
7-11	776-785	therefore	_	_	_	_
7-12	786-787	,	_	_	_	_
7-13	788-791	the	abstract[46]	new[46]	_	_
7-14	792-799	dietary	abstract[46]	new[46]	_	_
7-15	800-811	calibration	abstract[46]	new[46]	_	_
7-16	812-814	of	abstract[46]	new[46]	_	_
7-17	815-819	this	abstract[46]|substance[47]	new[46]|giv[47]	_	_
7-18	820-834	micronutrients	abstract[46]|substance[47]	new[46]|giv[47]	_	_
7-19	835-837	in	abstract[46]	new[46]	_	_
7-20	838-843	dairy	abstract[46]|person|animal[49]	new[46]|new|new[49]	coref|coref	11-15[98_49]|12-23
7-21	844-851	animals	abstract[46]|animal[49]	new[46]|new[49]	_	_
7-22	852-859	assumes	_	_	_	_
7-23	860-868	relevant	abstract[50]	new[50]	_	_
7-24	869-879	importance	abstract[50]	new[50]	_	_
7-25	880-882	in	abstract[50]	new[50]	_	_
7-26	883-888	order	abstract[50]	new[50]	_	_
7-27	889-891	to	abstract[50]	new[50]	_	_
7-28	892-898	obtain	abstract[50]	new[50]	_	_
7-29	899-905	I-rich	abstract[50]|substance[51]	new[50]|giv[51]	coref	10-24[89_51]
7-30	906-910	milk	abstract[50]|substance[51]	new[50]|giv[51]	_	_
7-31	911-918	without	_	_	_	_
7-32	919-927	inducing	_	_	_	_
7-33	928-938	variations	abstract[52]	new[52]	_	_
7-34	939-941	in	abstract[52]	new[52]	_	_
7-35	942-948	animal	abstract[52]|animal|event[54]	new[52]|new|new[54]	coref|coref	8-2|11-11[97_54]
7-36	949-961	performances	abstract[52]|event[54]	new[52]|new[54]	_	_
7-37	962-963	.	_	_	_	_

#Text=In animal husbandry , I supplementation as calcium iodate , sodium iodide , and other iodine compounds is needed since the native iodine content of plant straight feed-stuffs is low ;
8-1	964-966	In	_	_	_	_
8-2	967-973	animal	animal|animal[56]	giv|new[56]	_	_
8-3	974-983	husbandry	animal[56]	new[56]	_	_
8-4	984-985	,	_	_	_	_
8-5	986-987	I	person	giv	coref	10-18
8-6	988-1003	supplementation	abstract[58]	new[58]	coref	10-18[87_58]
8-7	1004-1006	as	abstract[58]	new[58]	_	_
8-8	1007-1014	calcium	abstract[58]|substance|substance[60]	new[58]|new|new[60]	_	_
8-9	1015-1021	iodate	abstract[58]|substance[60]	new[58]|new[60]	_	_
8-10	1022-1023	,	abstract[58]	new[58]	_	_
8-11	1024-1030	sodium	abstract[58]|substance|substance[62]	new[58]|new|new[62]	coref|coref	9-34|9-35[0_62]
8-12	1031-1037	iodide	abstract[58]|substance[62]	new[58]|new[62]	_	_
8-13	1038-1039	,	abstract[58]	new[58]	_	_
8-14	1040-1043	and	abstract[58]	new[58]	_	_
8-15	1044-1049	other	abstract[58]|substance[64]	new[58]|new[64]	_	_
8-16	1050-1056	iodine	abstract[58]|substance|substance[64]	new[58]|giv|new[64]	coref	8-23
8-17	1057-1066	compounds	abstract[58]|substance[64]	new[58]|new[64]	_	_
8-18	1067-1069	is	_	_	_	_
8-19	1070-1076	needed	_	_	_	_
8-20	1077-1082	since	_	_	_	_
8-21	1083-1086	the	abstract[66]	new[66]	coref	13-14[117_66]
8-22	1087-1093	native	abstract[66]	new[66]	_	_
8-23	1094-1100	iodine	substance|abstract[66]	giv|new[66]	coref	9-28
8-24	1101-1108	content	abstract[66]	new[66]	_	_
8-25	1109-1111	of	abstract[66]	new[66]	_	_
8-26	1112-1117	plant	abstract[66]|plant|substance[68]	new[66]|new|new[68]	_	_
8-27	1118-1126	straight	abstract[66]|substance[68]	new[66]|new[68]	_	_
8-28	1127-1138	feed-stuffs	abstract[66]|substance[68]	new[66]|new[68]	_	_
8-29	1139-1141	is	_	_	_	_
8-30	1142-1145	low	_	_	_	_
8-31	1146-1147	;	_	_	_	_

#Text=moreover , the increasing use of rapeseed meal ( RSM ) in livestock diets is associated with the intake of glucosinolates , which are known to be iodine antagonists inhibiting the activity of sodium iodide symporter .
9-1	1148-1156	moreover	_	_	_	_
9-2	1157-1158	,	_	_	_	_
9-3	1159-1162	the	event[69]	new[69]	_	_
9-4	1163-1173	increasing	event[69]	new[69]	_	_
9-5	1174-1177	use	event[69]	new[69]	_	_
9-6	1178-1180	of	event[69]	new[69]	_	_
9-7	1181-1189	rapeseed	event[69]|substance[70]	new[69]|new[70]	_	_
9-8	1190-1194	meal	event[69]|substance[70]	new[69]|new[70]	_	_
9-9	1195-1196	(	event[69]	new[69]	_	_
9-10	1197-1200	RSM	event[69]|abstract	new[69]|new	_	_
9-11	1201-1202	)	event[69]	new[69]	_	_
9-12	1203-1205	in	event[69]	new[69]	_	_
9-13	1206-1215	livestock	event[69]|animal|abstract[73]	new[69]|new|new[73]	coref	12-21[108_73]
9-14	1216-1221	diets	event[69]|abstract[73]	new[69]|new[73]	_	_
9-15	1222-1224	is	_	_	_	_
9-16	1225-1235	associated	_	_	_	_
9-17	1236-1240	with	_	_	_	_
9-18	1241-1244	the	event[74]	new[74]	_	_
9-19	1245-1251	intake	event[74]	new[74]	_	_
9-20	1252-1254	of	event[74]	new[74]	_	_
9-21	1255-1269	glucosinolates	event[74]|substance[75]	new[74]|new[75]	_	_
9-22	1270-1271	,	event[74]|substance[75]	new[74]|new[75]	_	_
9-23	1272-1277	which	event[74]|substance[75]	new[74]|new[75]	_	_
9-24	1278-1281	are	event[74]|substance[75]	new[74]|new[75]	_	_
9-25	1282-1287	known	event[74]|substance[75]	new[74]|new[75]	_	_
9-26	1288-1290	to	event[74]|substance[75]	new[74]|new[75]	_	_
9-27	1291-1293	be	event[74]|substance[75]	new[74]|new[75]	_	_
9-28	1294-1300	iodine	event[74]|substance[75]|substance|person[77]	new[74]|new[75]|giv|new[77]	coref	13-16
9-29	1301-1312	antagonists	event[74]|substance[75]|person[77]	new[74]|new[75]|new[77]	_	_
9-30	1313-1323	inhibiting	event[74]|substance[75]|person[77]	new[74]|new[75]|new[77]	_	_
9-31	1324-1327	the	event[74]|substance[75]|person[77]|abstract[78]	new[74]|new[75]|new[77]|new[78]	_	_
9-32	1328-1336	activity	event[74]|substance[75]|person[77]|abstract[78]	new[74]|new[75]|new[77]|new[78]	_	_
9-33	1337-1339	of	event[74]|substance[75]|person[77]|abstract[78]	new[74]|new[75]|new[77]|new[78]	_	_
9-34	1340-1346	sodium	event[74]|substance[75]|person[77]|abstract[78]|substance|person[81]	new[74]|new[75]|new[77]|new[78]|giv|new[81]	_	_
9-35	1347-1353	iodide	event[74]|substance[75]|person[77]|abstract[78]|substance|person[81]	new[74]|new[75]|new[77]|new[78]|giv|new[81]	coref	16-10[137_0]
9-36	1354-1363	symporter	event[74]|substance[75]|person[77]|abstract[78]|person[81]	new[74]|new[75]|new[77]|new[78]|new[81]	_	_
9-37	1364-1365	.	_	_	_	_

#Text=For this reason , the European community has recently brought to 5 mg/kg the maximum level of I supplementation for milk-producing ruminants ( milk intended for human consumption ) , while it remained at 10 mg/kg of complete feed for other ruminant categories .
10-1	1366-1369	For	_	_	_	_
10-2	1370-1374	this	abstract[82]	giv[82]	_	_
10-3	1375-1381	reason	abstract[82]	giv[82]	_	_
10-4	1382-1383	,	_	_	_	_
10-5	1384-1387	the	organization[83]	new[83]	_	_
10-6	1388-1396	European	organization[83]	new[83]	_	_
10-7	1397-1406	community	organization[83]	new[83]	_	_
10-8	1407-1410	has	_	_	_	_
10-9	1411-1419	recently	_	_	_	_
10-10	1420-1427	brought	_	_	_	_
10-11	1428-1430	to	_	_	_	_
10-12	1431-1432	5	substance[84]	new[84]	_	_
10-13	1433-1438	mg/kg	substance[84]	new[84]	_	_
10-14	1439-1442	the	abstract[85]	new[85]	_	_
10-15	1443-1450	maximum	abstract[85]	new[85]	_	_
10-16	1451-1456	level	abstract[85]	new[85]	_	_
10-17	1457-1459	of	abstract[85]	new[85]	_	_
10-18	1460-1461	I	abstract[85]|person|abstract[87]	new[85]|giv|giv[87]	coref|coref	11-18|11-17[100_87]
10-19	1462-1477	supplementation	abstract[85]|abstract[87]	new[85]|giv[87]	_	_
10-20	1478-1481	for	abstract[85]|abstract[87]	new[85]|giv[87]	_	_
10-21	1482-1496	milk-producing	abstract[85]|abstract[87]|animal[88]	new[85]|giv[87]|new[88]	coref	13-7[112_88]
10-22	1497-1506	ruminants	abstract[85]|abstract[87]|animal[88]	new[85]|giv[87]|new[88]	_	_
10-23	1507-1508	(	_	_	_	_
10-24	1509-1513	milk	substance[89]	giv[89]	coref	12-14[0_89]
10-25	1514-1522	intended	substance[89]	giv[89]	_	_
10-26	1523-1526	for	substance[89]	giv[89]	_	_
10-27	1527-1532	human	substance[89]|event[90]	giv[89]|new[90]	ana	10-32[0_90]
10-28	1533-1544	consumption	substance[89]|event[90]	giv[89]|new[90]	_	_
10-29	1545-1546	)	_	_	_	_
10-30	1547-1548	,	_	_	_	_
10-31	1549-1554	while	_	_	_	_
10-32	1555-1557	it	event	giv	_	_
10-33	1558-1566	remained	_	_	_	_
10-34	1567-1569	at	_	_	_	_
10-35	1570-1572	10	substance[92]	new[92]	_	_
10-36	1573-1578	mg/kg	substance[92]	new[92]	_	_
10-37	1579-1581	of	substance[92]	new[92]	_	_
10-38	1582-1590	complete	substance[92]|substance[93]	new[92]|new[93]	_	_
10-39	1591-1595	feed	substance[92]|substance[93]	new[92]|new[93]	_	_
10-40	1596-1599	for	substance[92]|substance[93]	new[92]|new[93]	_	_
10-41	1600-1605	other	substance[92]|substance[93]|abstract[95]	new[92]|new[93]|new[95]	_	_
10-42	1606-1614	ruminant	substance[92]|substance[93]|animal|abstract[95]	new[92]|new[93]|new|new[95]	_	_
10-43	1615-1625	categories	substance[92]|substance[93]|abstract[95]	new[92]|new[93]|new[95]	_	_
10-44	1626-1627	.	_	_	_	_

#Text=Consequently , several studies have been carried out to evaluate the productive performances in animals fed the I supplementation .
11-1	1628-1640	Consequently	_	_	_	_
11-2	1641-1642	,	_	_	_	_
11-3	1643-1650	several	abstract[96]	new[96]	coref	13-4[111_96]
11-4	1651-1658	studies	abstract[96]	new[96]	_	_
11-5	1659-1663	have	_	_	_	_
11-6	1664-1668	been	_	_	_	_
11-7	1669-1676	carried	_	_	_	_
11-8	1677-1680	out	_	_	_	_
11-9	1681-1683	to	_	_	_	_
11-10	1684-1692	evaluate	_	_	_	_
11-11	1693-1696	the	event[97]	giv[97]	_	_
11-12	1697-1707	productive	event[97]	giv[97]	_	_
11-13	1708-1720	performances	event[97]	giv[97]	_	_
11-14	1721-1723	in	event[97]	giv[97]	_	_
11-15	1724-1731	animals	event[97]|animal[98]	giv[97]|giv[98]	_	_
11-16	1732-1735	fed	event[97]|animal[98]	giv[97]|giv[98]	_	_
11-17	1736-1739	the	event[97]|animal[98]|abstract[100]	giv[97]|giv[98]|giv[100]	coref	12-16[106_100]
11-18	1740-1741	I	event[97]|animal[98]|person|abstract[100]	giv[97]|giv[98]|giv|giv[100]	coref	12-6
11-19	1742-1757	supplementation	event[97]|animal[98]|abstract[100]	giv[97]|giv[98]|giv[100]	_	_
11-20	1758-1759	.	_	_	_	_

#Text=Weiss et al. showed that I concentration increased in serum but not in milk after supplementation of this element in diets of dairy cows .
12-1	1760-1765	Weiss	person	new	_	_
12-2	1766-1768	et	_	_	_	_
12-3	1769-1772	al.	_	_	_	_
12-4	1773-1779	showed	_	_	_	_
12-5	1780-1784	that	_	_	_	_
12-6	1785-1786	I	person|abstract[103]	giv|new[103]	coref	13-11
12-7	1787-1800	concentration	abstract[103]	new[103]	_	_
12-8	1801-1810	increased	_	_	_	_
12-9	1811-1813	in	_	_	_	_
12-10	1814-1819	serum	substance	new	_	_
12-11	1820-1823	but	_	_	_	_
12-12	1824-1827	not	_	_	_	_
12-13	1828-1830	in	_	_	_	_
12-14	1831-1835	milk	substance	giv	coref	13-15
12-15	1836-1841	after	_	_	_	_
12-16	1842-1857	supplementation	abstract[106]	giv[106]	coref	13-11[114_106]
12-17	1858-1860	of	abstract[106]	giv[106]	_	_
12-18	1861-1865	this	abstract[106]|substance[107]	giv[106]|new[107]	_	_
12-19	1866-1873	element	abstract[106]|substance[107]	giv[106]|new[107]	_	_
12-20	1874-1876	in	abstract[106]|substance[107]	giv[106]|new[107]	_	_
12-21	1877-1882	diets	abstract[106]|substance[107]|abstract[108]	giv[106]|new[107]|giv[108]	_	_
12-22	1883-1885	of	abstract[106]|substance[107]|abstract[108]	giv[106]|new[107]|giv[108]	_	_
12-23	1886-1891	dairy	abstract[106]|substance[107]|abstract[108]|person|animal[110]	giv[106]|new[107]|giv[108]|giv|new[110]	coref|coref	18-19|18-19[162_110]
12-24	1892-1896	cows	abstract[106]|substance[107]|abstract[108]|animal[110]	giv[106]|new[107]|giv[108]|new[110]	_	_
12-25	1897-1898	.	_	_	_	_

#Text=In contrast , studies performed in small ruminants showed that I supplementation doubled the milk iodine content when compared with the control group , even though no evident effect was observed in the milk gross composition .
13-1	1899-1901	In	_	_	_	_
13-2	1902-1910	contrast	_	_	_	_
13-3	1911-1912	,	_	_	_	_
13-4	1913-1920	studies	abstract[111]	giv[111]	coref	19-30[172_111]
13-5	1921-1930	performed	abstract[111]	giv[111]	_	_
13-6	1931-1933	in	abstract[111]	giv[111]	_	_
13-7	1934-1939	small	abstract[111]|animal[112]	giv[111]|giv[112]	coref	19-42[0_112]
13-8	1940-1949	ruminants	abstract[111]|animal[112]	giv[111]|giv[112]	_	_
13-9	1950-1956	showed	_	_	_	_
13-10	1957-1961	that	_	_	_	_
13-11	1962-1963	I	person|abstract[114]	giv|giv[114]	coref|coref	14-1|14-1[123_114]
13-12	1964-1979	supplementation	abstract[114]	giv[114]	_	_
13-13	1980-1987	doubled	_	_	_	_
13-14	1988-1991	the	abstract[117]	giv[117]	_	_
13-15	1992-1996	milk	substance|abstract[117]	giv|giv[117]	coref	13-34
13-16	1997-2003	iodine	substance|abstract[117]	giv|giv[117]	coref	19-39
13-17	2004-2011	content	abstract[117]	giv[117]	_	_
13-18	2012-2016	when	_	_	_	_
13-19	2017-2025	compared	_	_	_	_
13-20	2026-2030	with	_	_	_	_
13-21	2031-2034	the	animal[118]	new[118]	_	_
13-22	2035-2042	control	animal[118]	new[118]	_	_
13-23	2043-2048	group	animal[118]	new[118]	_	_
13-24	2049-2050	,	_	_	_	_
13-25	2051-2055	even	_	_	_	_
13-26	2056-2062	though	_	_	_	_
13-27	2063-2065	no	abstract[119]	new[119]	_	_
13-28	2066-2073	evident	abstract[119]	new[119]	_	_
13-29	2074-2080	effect	abstract[119]	new[119]	_	_
13-30	2081-2084	was	_	_	_	_
13-31	2085-2093	observed	_	_	_	_
13-32	2094-2096	in	_	_	_	_
13-33	2097-2100	the	abstract[121]	new[121]	_	_
13-34	2101-2105	milk	substance|abstract[121]	giv|new[121]	coref	19-23
13-35	2106-2111	gross	abstract[121]	new[121]	_	_
13-36	2112-2123	composition	abstract[121]	new[121]	_	_
13-37	2124-2125	.	_	_	_	_

#Text=I supplementation showed also beneficial effects on healthy status .
14-1	2126-2127	I	person|abstract[123]	giv|giv[123]	coref|coref	16-9[138_123]|17-19
14-2	2128-2143	supplementation	abstract[123]	giv[123]	_	_
14-3	2144-2150	showed	_	_	_	_
14-4	2151-2155	also	_	_	_	_
14-5	2156-2166	beneficial	abstract[124]	new[124]	coref	17-25[150_124]
14-6	2167-2174	effects	abstract[124]	new[124]	_	_
14-7	2175-2177	on	abstract[124]	new[124]	_	_
14-8	2178-2185	healthy	abstract[124]|abstract[125]	new[124]|new[125]	_	_
14-9	2186-2192	status	abstract[124]|abstract[125]	new[124]|new[125]	_	_
14-10	2193-2194	.	_	_	_	_

#Text=Indeed , early study on feedlot cattle demonstrated an increased resistance to foot rot , which is due to improved phagocytic cell function .
15-1	2195-2201	Indeed	_	_	_	_
15-2	2202-2203	,	_	_	_	_
15-3	2204-2209	early	abstract[126]	new[126]	_	_
15-4	2210-2215	study	abstract[126]	new[126]	_	_
15-5	2216-2218	on	abstract[126]	new[126]	_	_
15-6	2219-2226	feedlot	abstract[126]|substance|animal[128]	new[126]|new|new[128]	_	_
15-7	2227-2233	cattle	abstract[126]|animal[128]	new[126]|new[128]	_	_
15-8	2234-2246	demonstrated	_	_	_	_
15-9	2247-2249	an	abstract[129]	new[129]	_	_
15-10	2250-2259	increased	abstract[129]	new[129]	_	_
15-11	2260-2270	resistance	abstract[129]	new[129]	_	_
15-12	2271-2273	to	abstract[129]	new[129]	_	_
15-13	2274-2278	foot	abstract[129]|object|event[131]	new[129]|new|new[131]	ana	16-3[0_131]
15-14	2279-2282	rot	abstract[129]|event[131]	new[129]|new[131]	_	_
15-15	2283-2284	,	abstract[129]	new[129]	_	_
15-16	2285-2290	which	abstract[129]	new[129]	_	_
15-17	2291-2293	is	abstract[129]	new[129]	_	_
15-18	2294-2297	due	abstract[129]	new[129]	_	_
15-19	2298-2300	to	abstract[129]	new[129]	_	_
15-20	2301-2309	improved	abstract[129]|abstract[133]	new[129]|new[133]	_	_
15-21	2310-2320	phagocytic	abstract[129]|abstract[133]	new[129]|new[133]	_	_
15-22	2321-2325	cell	abstract[129]|object|abstract[133]	new[129]|new|new[133]	_	_
15-23	2326-2334	function	abstract[129]|abstract[133]	new[129]|new[133]	_	_
15-24	2335-2336	.	_	_	_	_

#Text=Moreover , it was shown in lambs that high-dose potassium iodide supplementation can be effective to decrease the severity of airway viral infections , supposedly through the augmentation of mucosal oxidative defenses .
16-1	2337-2345	Moreover	_	_	_	_
16-2	2346-2347	,	_	_	_	_
16-3	2348-2350	it	event	giv	_	_
16-4	2351-2354	was	_	_	_	_
16-5	2355-2360	shown	_	_	_	_
16-6	2361-2363	in	_	_	_	_
16-7	2364-2369	lambs	animal	new	_	_
16-8	2370-2374	that	_	_	_	_
16-9	2375-2384	high-dose	abstract[138]	giv[138]	coref	17-19[148_138]
16-10	2385-2394	potassium	substance|substance[137]|abstract[138]	new|giv[137]|giv[138]	_	_
16-11	2395-2401	iodide	substance[137]|abstract[138]	giv[137]|giv[138]	_	_
16-12	2402-2417	supplementation	abstract[138]	giv[138]	_	_
16-13	2418-2421	can	_	_	_	_
16-14	2422-2424	be	_	_	_	_
16-15	2425-2434	effective	_	_	_	_
16-16	2435-2437	to	_	_	_	_
16-17	2438-2446	decrease	_	_	_	_
16-18	2447-2450	the	abstract[139]	new[139]	_	_
16-19	2451-2459	severity	abstract[139]	new[139]	_	_
16-20	2460-2462	of	abstract[139]	new[139]	_	_
16-21	2463-2469	airway	abstract[139]|substance|abstract[141]	new[139]|new|new[141]	_	_
16-22	2470-2475	viral	abstract[139]|abstract[141]	new[139]|new[141]	_	_
16-23	2476-2486	infections	abstract[139]|abstract[141]	new[139]|new[141]	_	_
16-24	2487-2488	,	_	_	_	_
16-25	2489-2499	supposedly	abstract[142]	new[142]	_	_
16-26	2500-2507	through	abstract[142]	new[142]	_	_
16-27	2508-2511	the	abstract[142]	new[142]	_	_
16-28	2512-2524	augmentation	abstract[142]	new[142]	_	_
16-29	2525-2527	of	abstract[142]	new[142]	_	_
16-30	2528-2535	mucosal	abstract[142]|abstract[143]	new[142]|new[143]	_	_
16-31	2536-2545	oxidative	abstract[142]|abstract[143]	new[142]|new[143]	_	_
16-32	2546-2554	defenses	abstract[142]|abstract[143]	new[142]|new[143]	_	_
16-33	2555-2556	.	_	_	_	_

#Text=Recently , the RNA-sequencing approach was shown to be useful to elucidate which molecular pathways are affected by I supplementation in sheeps and showed the positive effects of olive pomace-supplemented diet on inflammation and cholesterol in laying hens .
17-1	2557-2565	Recently	_	_	_	_
17-2	2566-2567	,	_	_	_	_
17-3	2568-2571	the	abstract[145]	new[145]	_	_
17-4	2572-2586	RNA-sequencing	abstract|abstract[145]	new|new[145]	_	_
17-5	2587-2595	approach	abstract[145]	new[145]	_	_
17-6	2596-2599	was	_	_	_	_
17-7	2600-2605	shown	_	_	_	_
17-8	2606-2608	to	_	_	_	_
17-9	2609-2611	be	_	_	_	_
17-10	2612-2618	useful	_	_	_	_
17-11	2619-2621	to	_	_	_	_
17-12	2622-2631	elucidate	_	_	_	_
17-13	2632-2637	which	abstract[146]	new[146]	coref	19-10[166_146]
17-14	2638-2647	molecular	abstract[146]	new[146]	_	_
17-15	2648-2656	pathways	abstract[146]	new[146]	_	_
17-16	2657-2660	are	_	_	_	_
17-17	2661-2669	affected	_	_	_	_
17-18	2670-2672	by	_	_	_	_
17-19	2673-2674	I	person|abstract[148]	giv|giv[148]	coref|coref	18-13|18-13[159_148]
17-20	2675-2690	supplementation	abstract[148]	giv[148]	_	_
17-21	2691-2693	in	abstract[148]	giv[148]	_	_
17-22	2694-2700	sheeps	abstract[148]|animal	giv[148]|new	_	_
17-23	2701-2704	and	_	_	_	_
17-24	2705-2711	showed	_	_	_	_
17-25	2712-2715	the	abstract[150]	giv[150]	_	_
17-26	2716-2724	positive	abstract[150]	giv[150]	_	_
17-27	2725-2732	effects	abstract[150]	giv[150]	_	_
17-28	2733-2735	of	abstract[150]	giv[150]	_	_
17-29	2736-2741	olive	abstract[150]|object|event[152]	giv[150]|new|giv[152]	_	_
17-30	2742-2761	pomace-supplemented	abstract[150]|event[152]	giv[150]|giv[152]	_	_
17-31	2762-2766	diet	abstract[150]|event[152]	giv[150]|giv[152]	_	_
17-32	2767-2769	on	abstract[150]	giv[150]	_	_
17-33	2770-2782	inflammation	abstract[150]|abstract	giv[150]|new	_	_
17-34	2783-2786	and	abstract[150]	giv[150]	_	_
17-35	2787-2798	cholesterol	abstract[150]|substance[154]	giv[150]|new[154]	_	_
17-36	2799-2801	in	abstract[150]|substance[154]	giv[150]|new[154]	_	_
17-37	2802-2808	laying	abstract[150]|substance[154]|animal[155]	giv[150]|new[154]|new[155]	_	_
17-38	2809-2813	hens	abstract[150]|substance[154]|animal[155]	giv[150]|new[154]|new[155]	_	_
17-39	2814-2815	.	_	_	_	_

#Text=However , to date , little is known about the effects of I supplementation on transcriptomic profiles in dairy cows .
18-1	2816-2823	However	_	_	_	_
18-2	2824-2825	,	_	_	_	_
18-3	2826-2828	to	_	_	_	_
18-4	2829-2833	date	time	new	_	_
18-5	2834-2835	,	_	_	_	_
18-6	2836-2842	little	_	_	_	_
18-7	2843-2845	is	_	_	_	_
18-8	2846-2851	known	_	_	_	_
18-9	2852-2857	about	_	_	_	_
18-10	2858-2861	the	abstract[157]	new[157]	_	_
18-11	2862-2869	effects	abstract[157]	new[157]	_	_
18-12	2870-2872	of	abstract[157]	new[157]	_	_
18-13	2873-2874	I	abstract[157]|person|abstract[159]	new[157]|giv|giv[159]	coref|coref	19-15|19-15[168_159]
18-14	2875-2890	supplementation	abstract[157]|abstract[159]	new[157]|giv[159]	_	_
18-15	2891-2893	on	abstract[157]	new[157]	_	_
18-16	2894-2908	transcriptomic	abstract[157]|abstract[160]	new[157]|new[160]	_	_
18-17	2909-2917	profiles	abstract[157]|abstract[160]	new[157]|new[160]	_	_
18-18	2918-2920	in	abstract[157]|abstract[160]	new[157]|new[160]	_	_
18-19	2921-2926	dairy	abstract[157]|abstract[160]|person|animal[162]	new[157]|new[160]|giv|giv[162]	_	_
18-20	2927-2931	cows	abstract[157]|abstract[160]|animal[162]	new[157]|new[160]|giv[162]	_	_
18-21	2932-2933	.	_	_	_	_

#Text=Moreover , we tried to correlate the information concerning the signaling pathways influenced by I supplementation , with the qualitative parameters of milk and derivatives , taking into account those studies in which it was shown that dietary iodine supplementation in ruminants contributes to an improvement in the quality of dairy products .
19-1	2934-2942	Moreover	_	_	_	_
19-2	2943-2944	,	_	_	_	_
19-3	2945-2947	we	person	acc	_	_
19-4	2948-2953	tried	_	_	_	_
19-5	2954-2956	to	_	_	_	_
19-6	2957-2966	correlate	_	_	_	_
19-7	2967-2970	the	abstract[164]	new[164]	ana	19-34[0_164]
19-8	2971-2982	information	abstract[164]	new[164]	_	_
19-9	2983-2993	concerning	abstract[164]	new[164]	_	_
19-10	2994-2997	the	abstract[164]|abstract[166]	new[164]|giv[166]	_	_
19-11	2998-3007	signaling	abstract[164]|abstract|abstract[166]	new[164]|new|giv[166]	_	_
19-12	3008-3016	pathways	abstract[164]|abstract[166]	new[164]|giv[166]	_	_
19-13	3017-3027	influenced	abstract[164]|abstract[166]	new[164]|giv[166]	_	_
19-14	3028-3030	by	abstract[164]|abstract[166]	new[164]|giv[166]	_	_
19-15	3031-3032	I	abstract[164]|abstract[166]|person|abstract[168]	new[164]|giv[166]|giv|giv[168]	coref	19-38[175_168]
19-16	3033-3048	supplementation	abstract[164]|abstract[166]|abstract[168]	new[164]|giv[166]|giv[168]	_	_
19-17	3049-3050	,	_	_	_	_
19-18	3051-3055	with	_	_	_	_
19-19	3056-3059	the	abstract[169]	new[169]	_	_
19-20	3060-3071	qualitative	abstract[169]	new[169]	_	_
19-21	3072-3082	parameters	abstract[169]	new[169]	_	_
19-22	3083-3085	of	abstract[169]	new[169]	_	_
19-23	3086-3090	milk	abstract[169]|substance	new[169]|giv	_	_
19-24	3091-3094	and	abstract[169]	new[169]	_	_
19-25	3095-3106	derivatives	abstract[169]|substance	new[169]|new	_	_
19-26	3107-3108	,	_	_	_	_
19-27	3109-3115	taking	_	_	_	_
19-28	3116-3120	into	_	_	_	_
19-29	3121-3128	account	_	_	_	_
19-30	3129-3134	those	abstract[172]	giv[172]	_	_
19-31	3135-3142	studies	abstract[172]	giv[172]	_	_
19-32	3143-3145	in	abstract[172]	giv[172]	_	_
19-33	3146-3151	which	abstract[172]	giv[172]	_	_
19-34	3152-3154	it	abstract[172]|abstract	giv[172]|giv	_	_
19-35	3155-3158	was	abstract[172]	giv[172]	_	_
19-36	3159-3164	shown	abstract[172]	giv[172]	_	_
19-37	3165-3169	that	_	_	_	_
19-38	3170-3177	dietary	abstract[175]	giv[175]	_	_
19-39	3178-3184	iodine	substance|abstract[175]	giv|giv[175]	_	_
19-40	3185-3200	supplementation	abstract[175]	giv[175]	_	_
19-41	3201-3203	in	abstract[175]	giv[175]	_	_
19-42	3204-3213	ruminants	abstract[175]|animal	giv[175]|giv	_	_
19-43	3214-3225	contributes	_	_	_	_
19-44	3226-3228	to	_	_	_	_
19-45	3229-3231	an	abstract[177]	new[177]	_	_
19-46	3232-3243	improvement	abstract[177]	new[177]	_	_
19-47	3244-3246	in	abstract[177]	new[177]	_	_
19-48	3247-3250	the	abstract[177]|abstract[178]	new[177]|new[178]	_	_
19-49	3251-3258	quality	abstract[177]|abstract[178]	new[177]|new[178]	_	_
19-50	3259-3261	of	abstract[177]|abstract[178]	new[177]|new[178]	_	_
19-51	3262-3267	dairy	abstract[177]|abstract[178]|abstract[179]	new[177]|new[178]|new[179]	_	_
19-52	3268-3276	products	abstract[177]|abstract[178]|abstract[179]	new[177]|new[178]|new[179]	_	_
19-53	3277-3278	.	_	_	_	_
